Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

UNKNOWN 1OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Meningeal Carcinomatosis 2Brain Neoplasms 2Thoracic Neoplasms 1Stomach Neoplasms 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Extranodal NK-T-Cell 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

S 1 (combination) 11titanium silicide 5Oxaliplatin 5Cisplatin 3nimotuzumab 2Surgical Procedures, Operative 2Docetaxel 2toripalimab 1raltitrexed 1pembrolizumab 1Trastuzumab 1Taxes 1Radiotherapy, Intensity-Modulated 1Paclitaxel 1Irinotecan 1Injections 1Chemotherapy, Adjuvant 1Capecitabine 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Stomach Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT02296658 2014-11-20

A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer

ChineseAMS

Phase 2 Unknown
60 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡